FDA clears remote monitor for heart failure

Published



WASHINGTON (AP) — The Food and Drug Administration has approved a new implantable device to help doctors monitor patients with severe heart failure as they go about their day.

The agency cleared the CardioMEMS HF system Wednesday for patients who have been hospitalized in the previous year due to heart failure.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.


Tag:

FDA